Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, PharmaCyte Biotech, Inc., holds the title of 10% Owner at Q/C TECHNOLOGIES, INC..
On 2026-11-18, the insider transacted 4,982,272 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
PharmaCyte Biotech, Inc. (10% Owner) exercised options for $0 of $QCLS
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.